VC
EW icon

Vestor Capital’s Edwards Lifesciences EW Stock Holding History

Vestor Capital’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.15M Buy
4,326
+1,386
+47% +$116K 0.07% 98
2026
Q1 		$235K Buy
2,940
+1,046
+55% +$86.2K 0.02% 148
2025
Q4 		$251K Sell
1,894
-1,046
-36% -$85.8K 0.02% 132
2025
Q3 		$229K Sell
2,940
-65,832
-96% -$5.14M 0.01% 152
2025
Q2 		$2.18M Buy
68,772
+65,832
+2,239% +$4.91M 0.16% 78
2025
Q1 		$213K Sell
2,940
-72
-2% -$5.15K 0.02% 133
2024
Q4 		$223K Buy
3,012
+18
+0.6% +$1.26K 0.02% 151
2024
Q3 		$198K Buy
2,994
+54
+2% +$3.92K 0.02% 129
2024
Q2 		$272K Hold
2,940
– – 0.02% 107
2024
Q1 		$281K Hold
2,940
– – 0.02% 119
2023
Q4 		$224K Buy
+2,940
New +$205K 0.02% 119

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Vestor Capital's EW Position: Q2 2026 in Review

Vestor Capital increased its Edwards Lifesciences (EW) stake by 47% in Q2 2026, buying an estimated $116K and bringing the position to 4,326 shares worth $1.15M. The position accounts for 0.07% of the portfolio, ranked #98.

Vestor Capital first reported a position in EW in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.18M in Q2 2025. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Vestor Capital held 4,326 shares of Edwards Lifesciences worth $1.15M as of Q2 2026.
  • Vestor Capital bought 1,386 Edwards Lifesciences shares in Q2 2026, an estimated $116K.
  • Edwards Lifesciences made up 0.07% of Vestor Capital's portfolio in Q2 2026, its #98 holding.
  • Vestor Capital first reported a position in Edwards Lifesciences in Q4 2023 and has held it in 11 quarters since.
  • Vestor Capital's Edwards Lifesciences position peaked at $2.18M in Q2 2025.
  • 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Vestor Capital's 13F filing for Q2 2026, filed 28 Jul 2026.